Senseonics Holdings, Inc.

[ Editor's Note: Several of the companies mentioned in this story will be presenting at the JP Morgan Healthcare Conference in San Francisco over the coming days, so look for updates to follow. Med

The diabetes devices sector has been steadily marching along in recent years with near-constant product releases and debuts of data. For a long time, the major players were able to carve out their own

After making its debut in the US, Senseonics Holdings, Inc. ’s next-generation, six-month Eversense E3 continuous glucose monitoring (CGM) received a CE mark, the company announced on 16 June. Senseo

Senseonics ’ modest revenue projections for 2022 disappointed investors, even as the company is touting the long-awaited US Food and Drug Administration approval of its next-generation Eversense E3 im